• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知障碍和阿尔茨海默病中的能量代谢紊乱和神经元回路功能障碍。

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

机构信息

Clinical Research Branch, National Institute on Aging Intramural Research Program, Baltimore, MD 21224, USA.

出版信息

Lancet Neurol. 2011 Feb;10(2):187-98. doi: 10.1016/S1474-4422(10)70277-5. Epub 2010 Dec 10.

DOI:10.1016/S1474-4422(10)70277-5
PMID:21147038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3026092/
Abstract

Epidemiological, neuropathological, and functional neuroimaging evidence implicates global and regional disruptions in brain metabolism and energetics in the pathogenesis of cognitive impairment. Nerve cell microcircuits are modified by excitatory and inhibitory synaptic activity and neurotrophic factors. Ageing and Alzheimer's disease cause perturbations in cellular energy metabolism, level of excitation or inhibition, and neurotrophic factor release, which overwhelm compensatory mechanisms and result in dysfunction of neuronal microcircuits and brain networks. A prolonged positive energy balance impairs the ability of neurons to adapt to oxidative and metabolic stress. Results from experimental studies in animals show how disruptions caused by chronic positive energy balance, such as diabetes, lead to accelerated cognitive ageing and Alzheimer's disease. Therapeutic interventions to allay cognitive dysfunction that target energy metabolism and adaptive stress responses (such as neurotrophin signalling) have been effective in animal models and in preliminary studies in humans.

摘要

流行病学、神经病理学和功能神经影像学证据表明,大脑代谢和能量的整体和区域紊乱与认知障碍的发病机制有关。神经细胞微电路通过兴奋性和抑制性突触活动以及神经营养因子进行修饰。衰老和阿尔茨海默病导致细胞能量代谢、兴奋或抑制水平以及神经营养因子释放的波动,这些波动超过了代偿机制,导致神经元微电路和大脑网络功能障碍。长期的正能平衡会损害神经元适应氧化和代谢应激的能力。动物实验研究的结果表明,慢性正能平衡(如糖尿病)引起的紊乱如何导致认知衰老和阿尔茨海默病的加速发生。针对能量代谢和适应性应激反应(如神经营养因子信号)的治疗干预措施在动物模型和人类初步研究中均有效,可以缓解认知功能障碍。

相似文献

1
Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.认知障碍和阿尔茨海默病中的能量代谢紊乱和神经元回路功能障碍。
Lancet Neurol. 2011 Feb;10(2):187-98. doi: 10.1016/S1474-4422(10)70277-5. Epub 2010 Dec 10.
2
Metabolic regional and network changes in Alzheimer's disease subtypes.阿尔茨海默病亚型的代谢区域性和网络变化。
J Cereb Blood Flow Metab. 2018 Oct;38(10):1796-1806. doi: 10.1177/0271678X17718436. Epub 2017 Jul 4.
3
Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease.天生保护:利用脑源性神经营养因子预防阿尔茨海默病认知缺陷。
CNS Drugs. 2020 Mar;34(3):281-297. doi: 10.1007/s40263-020-00705-9.
4
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.阿尔茨海默病认知障碍失认症的神经关联
Hum Brain Mapp. 2006 Jul;27(7):588-97. doi: 10.1002/hbm.20203.
5
Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.脑线粒体功能障碍作为阿尔茨海默病与糖尿病之间的联系。
J Neurol Sci. 2007 Jun 15;257(1-2):206-14. doi: 10.1016/j.jns.2007.01.017. Epub 2007 Feb 20.
6
Pathophysiology of neuronal energy crisis in Alzheimer's disease.阿尔茨海默病中神经元能量危机的病理生理学
Neurodegener Dis. 2008;5(3-4):126-32. doi: 10.1159/000113681. Epub 2008 Mar 6.
7
Brain aging and Alzheimer's disease; use it or lose it.大脑衰老与阿尔茨海默病;用进废退。
Prog Brain Res. 2002;138:343-73. doi: 10.1016/S0079-6123(02)38086-5.
8
Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.间歇性低氧预处理可挽救阿尔茨海默病三转基因小鼠模型的认知功能和线粒体生物能谱。
Int J Mol Sci. 2021 Jan 5;22(1):461. doi: 10.3390/ijms22010461.
9
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.淀粉样蛋白-β/Fyn 诱导的突触、网络和认知障碍依赖于阿尔茨海默病多种小鼠模型中的 tau 水平。
J Neurosci. 2011 Jan 12;31(2):700-11. doi: 10.1523/JNEUROSCI.4152-10.2011.
10
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.全脑葡萄糖代谢率比值在神经元网络失能中的诊断表现:在阿尔茨海默病和轻度认知障碍中的诊断意义。
Eur J Nucl Med Mol Imaging. 2019 May;46(5):1164-1174. doi: 10.1007/s00259-018-4248-0. Epub 2019 Jan 12.

引用本文的文献

1
Bridging the molecular and clinical aspects of resveratrol in Alzheimer's disease: a review.白藜芦醇在阿尔茨海默病中的分子与临床联系:综述
3 Biotech. 2025 Sep;15(9):284. doi: 10.1007/s13205-025-04451-x. Epub 2025 Aug 6.
2
Associations of age at menopause, bilateral oophorectomy, hysterectomy and hormone replacement therapy with glycaemia and risk of dementia: a study based on the population-based UK Biobank cohort.绝经年龄、双侧卵巢切除术、子宫切除术及激素替代疗法与血糖及痴呆风险的关联:一项基于英国生物银行人群队列的研究
BMJ Public Health. 2025 Jul 27;3(2):e002120. doi: 10.1136/bmjph-2024-002120. eCollection 2025.
3
Mitochondrial complex I deficiency induces Alzheimer's disease-like signatures that are reversible by targeted therapy.线粒体复合体I缺陷会诱发阿尔茨海默病样特征,而靶向治疗可使其逆转。
Alzheimers Dement. 2025 Aug;21(8):e70519. doi: 10.1002/alz.70519.
4
Alzheimer's Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2).阿尔茨海默病的致病机制:通过核因子红细胞2相关因子2(Nrf2)连接氧化还原稳态与线粒体相关代谢途径
Antioxidants (Basel). 2025 Jul 1;14(7):812. doi: 10.3390/antiox14070812.
5
Mitochondrial dysfunction mediated by ER-calcium dysregulation in neurons derived from Alzheimer's disease patients.阿尔茨海默病患者来源的神经元中,内质网钙失调介导的线粒体功能障碍。
Acta Neuropathol Commun. 2025 Jul 29;13(1):165. doi: 10.1186/s40478-025-02023-x.
6
Integrative bioinformatics and machine learning approaches reveal oxidative stress and glucose metabolism related genes as therapeutic targets and drug candidates in Alzheimer's disease.整合生物信息学和机器学习方法揭示氧化应激和葡萄糖代谢相关基因作为阿尔茨海默病的治疗靶点和候选药物。
Front Immunol. 2025 Jun 26;16:1572468. doi: 10.3389/fimmu.2025.1572468. eCollection 2025.
7
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's disease.与阿尔茨海默病穹窿深部脑刺激相关的生物标志物变化。
Alzheimers Dement. 2025 Jun;21(6):e70394. doi: 10.1002/alz.70394.
8
Vulnerability of mitochondrial OXPHOS complexes in the arcuate nucleus of the hypothalamus of Alzheimer's disease.阿尔茨海默病下丘脑弓状核中线粒体氧化磷酸化复合体的脆弱性。
J Alzheimers Dis. 2025 Aug;106(4):1545-1556. doi: 10.1177/13872877251352209. Epub 2025 Jun 22.
9
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease.阿尔茨海默病中有效重复经颅磁刺激的神经生物学基础。
Alzheimers Dement. 2025 Jun;21(6):e70337. doi: 10.1002/alz.70337.
10
Long-term consequences of COVID-19 on sleep, mental health, fatigue, and cognition: a preliminary study.新冠病毒病对睡眠、心理健康、疲劳和认知的长期影响:一项初步研究。
Discov Ment Health. 2025 May 1;5(1):66. doi: 10.1007/s44192-025-00193-7.

本文引用的文献

1
Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.大脑衰老和阿尔茨海默病中的分子变化在实验性沉默的皮质神经元网络中得到了反映。
Neurobiol Aging. 2012 Jan;33(1):205.e1-18. doi: 10.1016/j.neurobiolaging.2010.08.012. Epub 2010 Oct 13.
2
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.KATP 通道激活剂二氮嗪可改善阿尔茨海默病 3xTgAD 小鼠模型的淀粉样β和 tau 病理,并改善记忆。
J Alzheimers Dis. 2010;22(2):443-57. doi: 10.3233/JAD-2010-101017.
3
Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1.神经元通过 CREB 介导的嘌呤内切酶 1 的上调,有效地修复谷氨酸诱导的氧化 DNA 损伤。
J Biol Chem. 2010 Sep 3;285(36):28191-9. doi: 10.1074/jbc.M109.082883. Epub 2010 Jun 23.
4
Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys.与齿状回相比,海马体中与衰老相关的基因表达与恒河猴代谢综合征变量呈选择性相关。
J Neurosci. 2010 Apr 28;30(17):6058-71. doi: 10.1523/JNEUROSCI.3956-09.2010.
5
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice.Val(8)GLP-1 可挽救突触可塑性,减少 APP/PS1 小鼠的致密核心斑块。
Neurobiol Aging. 2012 Feb;33(2):265-76. doi: 10.1016/j.neurobiolaging.2010.02.014. Epub 2010 Mar 31.
6
Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.口服 GSK3 抑制剂可增加大脑胰岛素样生长因子 I 水平。
J Biol Chem. 2010 Jun 4;285(23):17693-700. doi: 10.1074/jbc.M109.096594. Epub 2010 Mar 29.
7
NOX activity in brain aging: exacerbation by high fat diet.脑衰老中的 NOX 活性:高脂肪饮食的加剧作用。
Free Radic Biol Med. 2010 Jul 1;49(1):22-30. doi: 10.1016/j.freeradbiomed.2010.03.006. Epub 2010 Mar 25.
8
Neural mechanisms of ageing and cognitive decline.衰老和认知能力下降的神经机制。
Nature. 2010 Mar 25;464(7288):529-35. doi: 10.1038/nature08983.
9
ER calcium and Alzheimer's disease: in a state of flux.内质网钙与阿尔茨海默病:变化不定。
Sci Signal. 2010 Mar 23;3(114):pe10. doi: 10.1126/scisignal.3114pe10.
10
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.GLP-1 受体刺激可减少阿尔茨海默病细胞和动物模型中的淀粉样β肽积累和细胞毒性。
J Alzheimers Dis. 2010;19(4):1205-19. doi: 10.3233/JAD-2010-1314.